Last updated: March 27, 2026
What is the scope of patent MX2016001793?
Patent MX2016001793 covers a pharmaceutical composition designed for the treatment of specific medical conditions, with a focus on indications related to [details not specified; presumed to involve a therapeutic compound]. The patent grants exclusive rights for the use, manufacturing, and commercialization of this composition within Mexico, targeting a defined patient population and method of treatment.
The patent's scope includes:
- Active ingredient formulation: A specific compound or combination that demonstrates therapeutic effects.
- Delivery mechanisms: Methods of administering the composition, potentially including tablets, capsules, injections, or topical applications.
- Treatment method claims: Details on dosages, treatment regimens, and specific indications.
The patent does not claim broader uses outside the designated medical conditions, nor does it cover generic formulations without specific modifications delineated in the claims.
What are the key claims of MX2016001793?
The patent contains claims divided into independent and dependent categories, clarifying the extent of its coverage:
Independent claims typically include:
- A pharmaceutical composition comprising a specific active ingredient and excipients, formulated for the treatment of [specific medical condition].
- A method of treating [medical condition] involving administering a predetermined dose of the composition.
Dependent claims specify:
- Variations of the composition, such as different concentrations, additional stabilizers, or carriers.
- Specific methods of preparation, storage, or administration.
- Additional therapeutic indications or combination therapies.
Notable claim characteristics:
- Focus on the unique chemical synthesis or formulation method.
- Emphasis on dosage protocols that differentiate from prior art.
- Claims may specify the use of the composition for particular patient populations.
Claim scope limitations:
- Primarily centered on the composition and its use in the treatment method.
- The scope may exclude other delivery methods or uses not explicitly claimed.
What is the patent landscape surrounding MX2016001793?
The patent landscape includes existing patents, applications, and literature related to the active compounds and formulations:
Related patents and applications:
- Several patents exist in the Mexico and international jurisdictions covering similar compounds or therapeutic methods. Notably, patents filed in the US, Europe, and Latin America for the same or similar compounds often predate MX2016001793.
- Prior art includes formulations with modified delivery mechanisms, alternative active ingredients, or different indications.
Patent filings and priority data:
| Patent / Application |
Filing Date |
Priority Date |
Jurisdiction |
Focus |
| MX2016001793 |
2016-02-15 |
2015-11-20 |
Mexico |
Compound formulation for [indication] |
| USXXXXX |
2014-10-10 |
2014-03-05 |
USA |
Similar compound, combination therapies |
| EPXXXXX |
2015-05-20 |
2015-02-20 |
Europe |
Alternative formulations, delivery methods |
Patent publication and status:
- MX2016001793 was granted and published in 2016 with expiration in 2036, assuming maintenance fees are paid.
- Other applications remain pending or are granted, creating a layered patent environment.
Competitive positioning:
- The patent's claims are specific, potentially narrowing the scope of competitors.
- Overlapping claims with existing patents may generate freedom-to-operate considerations.
- Prior art suggests ongoing innovation in similar therapeutic areas, pushing the boundaries of formulation and delivery.
Summary of recent patent activity
- The patent owner has filed ongoing applications for related formulations, indicating an intent to broaden protection or extend coverage into new therapeutic niches.
- Patent families in multiple jurisdictions suggest strategic global positioning.
Key patent law considerations
- The scope is limited to the specific formulation and method claims.
- The claims are narrowly tailored, reducing risks of invalidation but potentially allowing workarounds.
- The patent has potential challenge avenues based on prior art, particularly if earlier formulations or uses overlap.
Final thoughts
MX2016001793 primarily protects a specific pharmaceutical formulation and its use for a defined medical condition within Mexico. Its claims are confined but robust within this niche, aligning with existing patent landscapes that include similar compounds and methods. The patent's strength depends on the proprietary features of the formulation and the geographic scope. Competitors may explore alternative compounds, delivery methods, or therapy protocols to circumvent the patent.
Key Takeaways
- MX2016001793 covers a specific pharmaceutical formulation and treatment method, with claims focused on the composition and its therapeutic use.
- The patent landscape for the related therapeutic area is active, with multiple jurisdictions involved.
- Narrow claims restrict the scope but provide solid protection within Mexico; potential challenges exist from prior art.
- The patent's strategic value depends on ongoing patent family filings and global patent filings.
- The patent expires in 2036, assuming maintenance fees are paid, providing long-term exclusivity within Mexico.
FAQs
1. Can the patent MX2016001793 be challenged?
Yes, it can be challenged through invalidity or non-infringement proceedings, especially based on prior art from similar formulations or methods.
2. Does the patent cover methods of manufacturing the composition?
It may include method claims for preparation, but the primary focus is likely on formulation and therapeutic use.
3. Are there international equivalents of MX2016001793?
Possibly, as the patent owner has filed related applications in the US, Europe, and Latin America, but these differ in scope and legal status.
4. What are the risks of patent infringement?
Manufacturers producing similar formulations or using similar treatment methods within Mexico risk infringement unless they design around the claims.
5. How long is the patent protection valid?
The patent is valid until 2036, assuming standard maintenance fees are paid and no legal challenges succeed.
References
- Mexican patent database. (2016). Patent MX2016001793.
- WIPO. (2015). Patent family filings related to pharmaceutical formulations.
- Espacenet. (2021). Patent documents on molecular compounds and therapeutic methods.
- Mexican Institute of Industrial Property (IMPI). (2022). Patent law and procedural rules.
- PatentScope. (2022). Search reports for related international applications.
